126 related articles for article (PubMed ID: 23227587)
1. Individual response to drug therapy: bases and study approaches.
León-Cachón RB; Ascacio-Martínez JA; Barrera-Saldaña HA
Rev Invest Clin; 2012; 64(4):364-76. PubMed ID: 23227587
[TBL] [Abstract][Full Text] [Related]
2. DMET microarray technology for pharmacogenomics-based personalized medicine.
Burmester JK; Sedova M; Shapero MH; Mansfield E
Methods Mol Biol; 2010; 632():99-124. PubMed ID: 20217574
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacogenetics and its importance in the clinical].
Lares-Asseff I; Trujillo-Jiménez F
Gac Med Mex; 2001; 137(3):227-36. PubMed ID: 11432091
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of antipsychoatics.
Ozaki N
Nagoya J Med Sci; 2004 May; 67(1-2):1-7. PubMed ID: 15279062
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacogenomics: the quest for individualized therapy].
López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
[TBL] [Abstract][Full Text] [Related]
6. [Tailor-made drug therapy].
Ozawa S; Sawada J
Nihon Rinsho; 2001 Jan; 59(1):195-201. PubMed ID: 11197856
[TBL] [Abstract][Full Text] [Related]
7. Interplay of pharmacogenetic variations in ABCB1 transporters and cytochrome P450 enzymes.
Yoo HD; Lee YB
Arch Pharm Res; 2011 Nov; 34(11):1817-28. PubMed ID: 22139683
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacogenetics: current state after 30 years of research].
Eichelbaum M
Dtsch Med Wochenschr; 2013 Mar; 138(13):659-61. PubMed ID: 23512369
[No Abstract] [Full Text] [Related]
9. Cytochromes P450: decision-making tools for personalized therapeutics.
Murray M; Petrovic N
Curr Opin Mol Ther; 2006 Dec; 8(6):480-6. PubMed ID: 17243482
[TBL] [Abstract][Full Text] [Related]
10. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of osteoporosis: future perspectives.
Marini F; Brandi ML
Calcif Tissue Int; 2009 May; 84(5):337-47. PubMed ID: 19271099
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of cytochrome P450 genetic polymorphism--part I. Enzymatic system of cytochrome P450 and cytochrome P450 1A2].
Duricová J; Grundmann M
Ceska Slov Farm; 2011 Jun; 60(3):110-5. PubMed ID: 21838140
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacogenetics--pathway to individualized antihypertensive pharmacotherapy].
Kurland L; Lind L; Lithell H; Syvänen AC; Melhus H
Lakartidningen; 2003 Feb; 100(8):600-3. PubMed ID: 12640971
[TBL] [Abstract][Full Text] [Related]
14. [Characteristics and design of the studies evaluating pharmacological interactions].
Montané E; López A; Costa J
Med Clin (Barc); 2013 Jul; 141(2):82-6. PubMed ID: 23706685
[No Abstract] [Full Text] [Related]
15. Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics.
Johnson AD; Wang D; Sadee W
Pharmacol Ther; 2005 Apr; 106(1):19-38. PubMed ID: 15781120
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacogenetics or "farm-ecogenetics"?].
Gérard N; Elion J; Krishnamoorthy R
J Soc Biol; 2000; 194(1):9-13. PubMed ID: 11107543
[TBL] [Abstract][Full Text] [Related]
17. Genetic factors in drug metabolism.
Belle DJ; Singh H
Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
[TBL] [Abstract][Full Text] [Related]
18. A question-based approach to adopting pharmacogenetics to understand risk for clinical variability in pharmacokinetics in early drug development.
Evers R; Blanchard RL; Warner AW; Cutler D; Agrawal NG; Shaw PM
Clin Pharmacol Ther; 2014 Sep; 96(3):291-5. PubMed ID: 25141952
[TBL] [Abstract][Full Text] [Related]
19. Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcome.
Mourad M; Wallemacq P; De Meyer M; Malaise J; De Pauw L; Eddour DC; Goffin E; Lerut J; Haufroid V
Transplantation; 2008 Apr; 85(7 Suppl):S19-24. PubMed ID: 18401258
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of hepatic enzyme activities of drug metabolizing enzymes-phenotyping and genotyping].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1999; (117):63-76. PubMed ID: 10859937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
